Experts in the scientific management of pharmacoepidemiology research and regulatory science
Real-World Evidence (RWE) Studies
We provide scientific management in pharmacoepidemiology, safety and effectiveness studies of medicines and vaccines based on real-world evidence
Active Studies
Pfizer Comirnaty PASS
Pfizer Comirnaty PASS
Network: VAC4EU
Duration: 2021-2025
Partners: 12
Countries: 5
Scientific Coordinator: UMCU
Protocol: EUPAS41623
Pfizer Comirnaty Myo/Pericarditis PASS
Pfizer Comirnaty Myo/Pericarditis PASS
Network: VAC4EU
Duration: 2023-2025
Partners: 12
Countries: 5
Scientific Coordinator: UMCU
Protocol: EUPAS47708
Pfizer Bivalent PASS
Pfizer Bivalent PASS
Network: VAC4EU
Duration: 2024-2026
Partners: 10
Countries: 5
Scientific Coordinator: UMCU
Protocol: EUPAS108847
Pfizer Abrysvo PASS
Pfizer Abrysvo PASS
Network: VAC4EU
Duration: 2024-2029
Partners: 13
Countries: 7
Scientific Coordinator: UMCU
Protocol: Pass 12
J&J Jcovden PASS
J&J Jcovden PASS
Network: VAC4EU
Duration: 2022-2025
Partners: 6
Countries: 2
Scientific Coordinator: UMCU
Protocol: EUPAS45362
UCB Evenity PASS
UCB Evenity PASS
Network: EU-ADR Alliance
Duration: 2020-2026
Partners: 7
Countries: 5
Scientific Coordinator: Oxford
Protocol: EUPAS36005
Closed Studies
Covid-Vaccine-Monitor (CVM)
Covid-Vaccine-Monitor (CVM)
Network: EUPE&PV Network and VAC4EU
Duration: 2021-2023
Partners: 29
Countries: 14
Scientific Coordinator: UMCU
Protocol: EUPAS39798 - EUPAS42467 - EUPAS42504
Covid Vaccines Effectiveness (CoVE)
Covid Vaccines Effectiveness (CoVE)
Network: EUPE&PV Network and VAC4EU
Duration: 2023
Partners: 17
Countries: 4
Scientific Coordinator: AEMPS
Protocol: EUPAS47725
GVDN COVID-19 Association (GCoVS)
GVDN COVID-19 Association (GCoVS)
Network: GVDN
Duration: 2024-2026
Partners: 12
Countries: 10
Scientific Coordinator: UMCU
Sanofi Vidprevtyn beta PASS (Feasibility)
Sanofi Vidprevtyn beta PASS (Feasibility)
Network: VAC4EU
Duration: 2024-2026
Partners: 7
Countries: 6
Scientific Coordinator: BPE
Vaccines Safety Framework (SAFETY-VAC)
Vaccines Safety Framework (SAFETY-VAC)
Network: EUPE&PV Network and VAC4EU
Duration: 2023-2025
Partners: 17
Countries: 8
Scientific Coordinator: UMCU
Protocol: EUPAS1000000193, EUPAS1000000233, EUPAS1000000288
Research Networks Management
We are experts in the coordination, governance and business development of multistakeholder international networks dedicated to pharmacoepidemiology research.
Vaccine monitoring collaboration for Europe (VAC4EU) is an international network that fosters real world evidence creation on vaccine coverage, safety, and effectiveness. VAC4EU has 24 members, from 9 European countries, and 17 data partners covering an overall population of 152 million.
Our role:
Business Development
Scientific Research Management
Quality Framework
Communication, Dissemination & Outreach Strategy
The European Pharmacoepidemiology and Pharmacovigilance (EU PE&PV) Research Network conducts research projects on the real-world effectiveness and safety of medicines and the impact of medicines' regulatory interventions. The network brings together more than 50 research centers in 21 European countries.
Our role:
Scientific research management
Business Developmen
Quality Framework
The Exploring and Understanding Adverse Drug Reactions (EU-ADR) Alliance is a European collaboration framework that conducts multi-database studies to answer pharmacoepidemiologic and drug safety questions, covering about 20 million active population.
Our role:
Business Development
Scientific Research Management
